Simultaneous targeting of AMPK and mTOR is a novel therapeutic strategy against prostate cancer
G. Zhao, G. Forn-Cuni, M. Scheers, P. P. Lindenbergh, J. Yin, Q. van Loosen, L. Passarini, L. Chen, E. B. Snaar
This study shows that targeting both AMPK and mTOR can inhibit prostate cancer metastasis by blocking the metabolic switch required for tumor growth in new environments.
bioRxiv · Aug 14, 2023Cancer Biology